News about Drug Discovery & Development

Moderna reports positive results from phase 3 efficacy study of P304 for seasonal influenza vaccine

In a previous phase 3 study, mRNA-1010 had already demonstrated superior seroconversion rates and geometric mean titer ratios (GMR) against all strains included in the vaccine compared to both high-dose and standard-dose licensed seasonal influenza vaccine.

Drug Discovery & Development | 02/07/2025 | By Darshana |  404

Iksuda Therapeutics Secures FDA IND Clearance for IKS014

Iksuda Therapeutics has received FDA clearance for its IND application for IKS014, a HER2-targeting antibody drug conjugate, paving the way for US site participation in its ongoing Phase 1 trial for advanced HER2-positive solid tumours.

Drug Discovery & Development | 02/07/2025 | By Mrinmoy Dey |  239

Lupin receives US FDA approval for loteprednol etabonate ophthalmic gel

Loteprednol etabonate ophthalmic gel, 0.38% is bioequivalent to Lotemax SM ophthalmic gel of Bausch & Lomb Inc. Lupin is the exclusive first-to-file for this product and is eligible for 180 days of generic drug exclusivity. This product will be manufactured at Lupin’s Pithampur facility in India.<br />

Drug Discovery & Development | 02/07/2025 | By Darshana |  334

Nona Biosciences and Visterra Join Hands to Develop Next-Gen Biotherapeutics Targeting Immune and Autoimmune Disorders

Nona Biosciences has entered into a license agreement with Visterra, Inc. to accelerate the development of next-generation biotherapeutics for immune-mediated and autoimmune diseases using its proprietary HCAb Harbour Mice platform.

Drug Discovery & Development | 13/06/2025 | By Manvi |  181

NVIDIA partners with Novo Nordisk and DCAI to advance drug discovery

The companies aim to create customized AI models and agents that Novo Nordisk can use for early research and clinical development and to apply advanced simulation and physical AI technologies.

Drug Discovery & Development | 12/06/2025 | By Darshana |  259

Government Invites Fresh Applications Under PLI Scheme to Boost Bulk Drugs Production

Department of Pharmaceuticals has invited fresh applications under the performance-linked incentive (PLI) to boost bulk drug production. Focus will be on 11 key APIs, KSMs, and intermediates amid continued reliance on China. INR 6,940 crore outlay aims to strengthen domestic pharma manufacturing and reduce import dependency.

Drug Discovery & Development | 16/05/2025 | By Manvi |  671

STEERLife Redefines Potent Drug Development with Solvent-free Continuous Processing

STEERLife, the life sciences arm of STEER World, is transforming the development and manufacturing of complex and potent drug products through its proprietary solvent-free continuous processing technology.

Drug Discovery & Development | 15/05/2025 | By Manvi |  514

Cyrano Therapeutics Completes Enrollment in Phase 2 FLAVOR Trial of CYR-064 for Post-Viral Smell Loss

Cyrano Therapeutics has completed enrollment in its Phase 2 FLAVOR trial evaluating CYR-064, a novel soft-mist nasal spray for the treatment of post-viral smell loss, with results expected in late 2025.

Drug Discovery & Development | 10/04/2025 | By Manvi |  474

ProFuse Launches Drug Discovery Platform for Prevention of Muscle Loss

ProFuse's technology is based on developing methods to generate highly mature muscle tissues that accurately reflect the structure and function of natural human muscle.

Drug Discovery & Development | 05/04/2025 | By Aishwarya |  315

IRBM Expands Functional Genomics Platform to Boost Early Drug Discovery

The platform integrates CRISPR-based methodologies, screening capabilities, cell engineering, and advanced molecular and cellular analysis to drive both target discovery and validation.

Drug Discovery & Development | 05/04/2025 | By Aishwarya |  389